Clinical Trial Update: An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients

View source ↗

Summary

An observational study evaluating the re-treatment of chronic hepatitis C with a triple therapy of boceprevir, peginterferon alfa-2a, and ribavirin; the trial w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• Victrelis (boceprevir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Status: TERMINATED | Results posted: 2016-12-12